The direct-to-consumer genetic testing market size was estimated at US$ 1.59 billion in 2022 it is predicted to grow at a CAGR of 24.33% from 2023 to 2032 to reach around US$ 14.03 billion by the end of 2032.
The direct-to-consumer genetic testing market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global direct-to-consumer genetic testing market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global direct-to-consumer genetic testing market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Bn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40299
Report Scope of the Direct-to-Consumer Genetic Testing Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 60.13% |
| Revenue Forecast by 2032 | USD 14.03 billion |
| Growth Rate from 2023 to 2032 | CAGR of 24.33% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | 23andMe; Family Tree DNA; Ancestry; Genesis HealthCare; EasyDNA; Veritas; Myriad Genetics Inc.; Full Genomes Corporation, Inc.; Living DNA Ltd.; Color Health, Inc., |
This study covers an elaborate segmentation of the global direct-to-consumer genetic testing market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global direct-to-consumer genetic testing market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Market Segmentation
By Test Type
- Nutrigenomics Testing
- Predictive Testing
- Carrier Testing
- Others
By Technology
- Whole Genome Sequencing
- Single Nucleotide Polymorphism Chips
- Targeted Analysis
- Others
By Distributional
- Online Platform
- OTC
By Regional
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Research Methodology
The research methodology acquire by analysts for assemble the global direct-to-consumer genetic testing market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global direct-to-consumer genetic testing market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Test Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Direct-to-Consumer Genetic Testing Market
5.1. COVID-19 Landscape: Direct-to-Consumer Genetic Testing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Direct-to-Consumer Genetic Testing Market, By Test Type
8.1. Direct-to-Consumer Genetic Testing Market, by Test Type, 2023-2032
8.1.1 Nutrigenomics Testing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Predictive Testing
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Carrier Testing
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Direct-to-Consumer Genetic Testing Market, By Technology
9.1. Direct-to-Consumer Genetic Testing Market, by Technology, 2023-2032
9.1.1. Whole Genome Sequencing
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Single Nucleotide Polymorphism Chips
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Targeted Analysis
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Direct-to-Consumer Genetic Testing Market, By Distributional Channel
10.1. Direct-to-Consumer Genetic Testing Market, by Distributional Channel, 2023-2032
10.1.1. Online Platform
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. OTC
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Direct-to-Consumer Genetic Testing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Technology (2020-2032)
11.1.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.5.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Distributional Channel (2020-2032)
Chapter 12. Company Profiles
12.1. 23andMe
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Family Tree DNA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ancestry
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Genesis HealthCare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. EasyDNA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Veritas
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Myriad Genetics Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Full Genomes Corporation, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Living DNA Ltd.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Color Health, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168